These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16096437)

  • 1. Effect of exemestane on the lipidemic profile of post-menopausal operable breast cancer patients following 5-7 years of adjuvant tamoxifen: preliminary results of the ATENA substudy.
    Markopoulos C; Chrissochou M; Michailidou A; Tzoracoleftherakis E; Xepapadakis G; Papadiamantis J; Misitzis J; Zobolas V; Bafaloukos D; Gogas H
    Anticancer Drugs; 2005 Sep; 16(8):879-83. PubMed ID: 16096437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy.
    Markopoulos C; Dafni U; Misitzis J; Zobolas V; Tzoracoleftherakis E; Koukouras D; Xepapadakis G; Papadiamantis J; Venizelos B; Antonopoulou Z; Gogas H
    Breast Cancer Res; 2009; 11(3):R35. PubMed ID: 19531217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study.
    Markopoulos C; Polychronis A; Zobolas V; Xepapadakis G; Papadiamantis J; Koukouras D; Lappas H; Gogas H
    Breast Cancer Res Treat; 2005 Sep; 93(1):61-6. PubMed ID: 16184460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'.
    Atalay G; Dirix L; Biganzoli L; Beex L; Nooij M; Cameron D; Lohrisch C; Cufer T; Lobelle JP; Mattiaci MR; Piccart M; Paridaens R
    Ann Oncol; 2004 Feb; 15(2):211-7. PubMed ID: 14760111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid changes in breast cancer patients on exemestane treatment: final results of the TEAM Greek substudy.
    Markopoulos C; Polychronis A; Dafni U; Koukouras D; Zobolas V; Tzorakoleftherakis E; Xepapadakis G; Gogas H
    Ann Oncol; 2009 Jan; 20(1):49-55. PubMed ID: 18678766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study.
    Hozumi Y; Suemasu K; Takei H; Aihara T; Takehara M; Saito T; Ohsumi S; Masuda N; Ohashi Y
    Ann Oncol; 2011 Aug; 22(8):1777-82. PubMed ID: 21285133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer.
    Montagnani A; Gonnelli S; Cadirni A; Caffarelli C; Del Santo K; Pieropan C; Campagna MS; Montomoli M; Petrioli R; Nuti R
    Eur J Intern Med; 2008 Dec; 19(8):592-7. PubMed ID: 19046724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)--a randomised controlled trial of exemestane versus continued tamoxifen after 2-3 years tamoxifen.
    Bertelli G; Hall E; Ireland E; Snowdon CF; Jassem J; Drosik K; Karnicka-Mlodkowska H; Coombes RC; Bliss JM
    Ann Oncol; 2010 Mar; 21(3):498-505. PubMed ID: 19717534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysis.
    van de Water W; Fontein DB; van Nes JG; Bartlett JM; Hille ET; Putter H; Robson T; Liefers GJ; Roumen RM; Seynaeve C; Dirix LY; Paridaens R; Kranenbarg EM; Nortier JW; van de Velde CJ
    Eur J Cancer; 2013 Jan; 49(2):297-304. PubMed ID: 22954666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids.
    Francini G; Petrioli R; Montagnani A; Cadirni A; Campagna S; Francini E; Gonnelli S
    Br J Cancer; 2006 Jul; 95(2):153-8. PubMed ID: 16835585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.
    Coleman RE; Banks LM; Girgis SI; Kilburn LS; Vrdoljak E; Fox J; Cawthorn SJ; Patel A; Snowdon CF; Hall E; Bliss JM; Coombes RC;
    Lancet Oncol; 2007 Feb; 8(2):119-27. PubMed ID: 17267326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.
    Derks MGM; Blok EJ; Seynaeve C; Nortier JWR; Kranenbarg EM; Liefers GJ; Putter H; Kroep JR; Rea D; Hasenburg A; Markopoulos C; Paridaens R; Smeets JBE; Dirix LY; van de Velde CJH
    Lancet Oncol; 2017 Sep; 18(9):1211-1220. PubMed ID: 28732650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of tamoxifen effect on lipidemic profile of postmenopausal breast cancer patients following deprivation of treatment.
    Markopoulos C; Chrissochou M; Antonopoulou Z; Xepapadakis G; Papadiamantis J; Tzoracoleftherakis E; Gogas H
    Oncology; 2006; 70(4):301-5. PubMed ID: 17047401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of aromatase inactivators in the treatment of breast cancer.
    Lønning PE
    Int J Clin Oncol; 2002 Aug; 7(4):265-70. PubMed ID: 12202980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial effects of exemestane compared to tamoxifen within the Tamoxifen Exemestane Adjuvant Multicenter (TEAM) trial: results of a prospective gynecological ultrasound substudy.
    Kieback DG; Harbeck N; Bauer W; Hadji P; Weyer G; Menschik T; Hasenburg A
    Gynecol Oncol; 2010 Dec; 119(3):500-5. PubMed ID: 20832103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study.
    Bliss JM; Kilburn LS; Coleman RE; Forbes JF; Coates AS; Jones SE; Jassem J; Delozier T; Andersen J; Paridaens R; van de Velde CJ; Lønning PE; Morden J; Reise J; Cisar L; Menschik T; Coombes RC
    J Clin Oncol; 2012 Mar; 30(7):709-17. PubMed ID: 22042946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04).
    Takei H; Ohsumi S; Shimozuma K; Takehara M; Suemasu K; Ohashi Y; Hozumi Y
    Breast Cancer Res Treat; 2012 May; 133(1):227-36. PubMed ID: 22234519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole.
    Bell LN; Nguyen AT; Li L; Desta Z; Henry NL; Hayes DF; Wolff AC; Stearns V; Storniolo AM; Flockhart DA;
    J Clin Pharmacol; 2012 Dec; 52(12):1852-60. PubMed ID: 22174434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.
    van de Velde CJ; Rea D; Seynaeve C; Putter H; Hasenburg A; Vannetzel JM; Paridaens R; Markopoulos C; Hozumi Y; Hille ET; Kieback DG; Asmar L; Smeets J; Nortier JW; Hadji P; Bartlett JM; Jones SE
    Lancet; 2011 Jan; 377(9762):321-31. PubMed ID: 21247627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
    Jahanzeb M
    Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.